Replies to post #17648 on GOOD TRADERS FORUM

[powerbattles]

IMUN :)))) AHR AMERICAN HOSPITALS TREATMENT WITH LODONAL.

http://www.americanhospitals.org/lodonal/

http://www.americanhospitals.org/

Shipment of Lodonal 100,000 capsules of Lodonal purchase order for $195,000
http://www.cytocom.com/lodonal/

Lodonal, that modulating immune system function and decreases inflammation and has previously been shown effective to treat viral infections (HIV and H1N1). There is compelling biomedical rationale to test Lodonal for the therapeutic intervention of COVID-19 in patients and as prophylactic agent to attenuate the spread of the disease. The U.S. government needs to act quickly and implement the use of Lodonal both prophylactically and therapeutically to stem the spread or “flatten the curve” of the virus.

https://www.immunetherapeutics.com/2020/03/covid19_virus_concept_sheet/

“Low-dose naltrexone (Lodonal or LDN) is a safe, inexpensive, yet underused drug that is extremely beneficial for people with conditions marked by immune system dysfunction.

"Doctors from all over the World will give presentations at this year's
LDN Research Trust World Conference in Oregon. It is estimated that in
2017, 300,000 people Globally take LDN and all of this only happens
because LDN helps so many people so much....

Elsa Oden
I have been on LDN for almost 4 yrs now. And can't say enough great about it! I have MS, Hashimotos and high cancer level in my family. This has helped with Hashimotos (even when I wasn't taking my Thyroid meds) and has kept me from having any major episodes form the MS in 4 years. This to me is a miracle medicine!! I had to give up my occasional alcohol, but it's worth it! In 2011 in was diagnosed with the MS and was told if stress levels weren't controlled, I would be paralyzed within 10 years. This episode caused me to be numb from waist down for 6 weeks. I started LDN 2 years later as I was having another numbing episode. I have not had anymore since. Even the headaches and muscle spasms from MS have reduced. Love this medicine!!

NAFDAC Approval

Immune Therapeutics, Inc. (OTCQB:IMUN) (the “Company”), a clinical-stage biotech company providing immunotherapy solutions for the treatment of autoimmune disease and cancer with a focus on emerging nations, today announced that Nigeria’s National Agency for Food and Drug Administration and Control (NAFDAC) has approved its patented Lodonal as an over the counter, non-toxic adjunct therapy in the treatment of HIV/AIDS and immune system regulator.

The receipt of NAFDAC’s approval will enable the Company’s distribution partner, AHAR Pharma, and GB Pharma Holdings, to launch a nationwide marketing and sales program that is expected to generate new and significant revenue channels for the Company. The Company believes that this new sales revenue places it on-track towards achieving profitability and significant future revenue and earnings growth.

Phase III Trails: A number of phase I and phase II trials have shown Lodonal to benefit in the treatment of HIV/AIDS, cancer and autoimmune diseases. Where there is continued research with Lodonal until recently there was no one Biotech Company interested in completing phase III trials with Lodonal. The body of research is growing rapidly, along with clinical experience and Lodonal certainly seems to work for many people. Which is why one small company Immune Therapeutics has moved forward with acquiring all of the patents and clinical work surrounding LDN so that they can obtain regulatory approval for Lodonal in emerging nations while Cytocom is working with the FDA and EMA for Lodonal approval in the United States and EU.

Immune Therapeutics, Inc. Announces Exclusive Agreement for Sale of Lodonal in Kenya Valued at Over $31 Million

https://www.publicwire.com/immune-therapeutics-inc-announces-exclusive-agreement-for-sale-of-lodonal-in-kenya-valued-at-over-31-million/

Immune Therapeutics, Inc. Announces First Sales & Shipment of Lodonal; Receives Trademark and Patent Approval From Federal Republic of Nigeria
https://www.publicwire.com/tag/lodonal/